Table 2. Studies consisting of more than 10 patients undergoing superior vena cava resection and reconstruction due to mediastinal pathologies.

Authors	Year	N	n	Pathology	Mortality		Morbidity		Occlusion
					n	%	n	%	n	%
Dartevelle et al.[5]	1991	22	16	MMT	0	0	1	6	1 early	13
									1 late
Bacha et al.[6]	1998	21	21	MMT	NS		NS		1 early	10
									1 late
Shintani et al.[7]	2005	18	18	MMT	0	0	6	33	10	56
Chen et al.[8]	2006	15	15	MMT	0	0	2	13	NG
Picquet et al.[2]	2009	24	12	MMT + BMD	1	8	1	8	0	0
Sekine et al.[9]	2010	20	11	MMT	0	0	13	65*	NS
Leo et al.[11]	2010	28	17	MMT	1	4*	6	21*	2 in-hospital*	18
									3 early*
Okereke et al.[10]	2010	38	29	MMT + BMD	3	8*	8	21*	2*	5
Lee et al.[12]	2016	16	15	MMT	0	0	NS		7	47
This study	2016	17	17	MMT + BMD	3	18	5	29	0	0
N: Total number of the patients with both mediastinal and pulmonary pathologies undergoing SVC resection and reconstruction; n: Total number of the patients with only mediastinal pathologies undergoing SVC resection and reconstruction; MMT: Malignant mediastinal tumor; BMD: Benign mediastinal disease; NS: Not specific; NG: Not given; * According to N.